1. Home
  2. SOAR vs BIAF Comparison

SOAR vs BIAF Comparison

Compare SOAR & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Volato Group Inc.

SOAR

Volato Group Inc.

HOLD

Current Price

$0.32

Market Cap

4.5M

Sector

Finance

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.88

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOAR
BIAF
Founded
2021
2014
Country
United States
United States
Employees
13
57
Industry
Blank Checks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SOAR
BIAF
Price
$0.32
$1.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.0M
192.2K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.95
Revenue Next Year
N/A
N/A
P/E Ratio
$0.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.23
52 Week High
$4.36
$13.50

Technical Indicators

Market Signals
Indicator
SOAR
BIAF
Relative Strength Index (RSI) 62.41 48.93
Support Level $0.28 $1.81
Resistance Level $0.35 $3.58
Average True Range (ATR) 0.05 0.20
MACD 0.03 0.05
Stochastic Oscillator 57.78 65.81

Price Performance

Historical Comparison
SOAR
BIAF

About SOAR Volato Group Inc.

Volato Group Inc is an aviation technology company that connects travelers to private, on-demand flight access and develops proprietary software platforms for enterprise and operational applications. The company operates in a single operating and reportable segment, private aviation services. It operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: